127 related articles for article (PubMed ID: 1966473)
1. In vitro immunization of human B lymphocytes with cultured melanoma cells (SK-MEL 28).
Zhang XM; Borrebaeck CA
Hum Antibodies Hybridomas; 1990; 1(1):42-6. PubMed ID: 1966473
[TBL] [Abstract][Full Text] [Related]
2. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
de Vries JE; Spits H
J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
[TBL] [Abstract][Full Text] [Related]
3. In vitro immunization. Effect of growth and differentiation factors on antigen-specific B cell activation and production of monoclonal antibodies to autologous antigens and weak immunogens.
Borrebaeck CA; Möller SA
J Immunol; 1986 May; 136(10):3710-5. PubMed ID: 3486221
[TBL] [Abstract][Full Text] [Related]
4. Pokeweed mitogen-stimulated human lymphocytes fused to LICR-2 (HMY2) generate human-human hybridomas producing monoclonal IgG antibodies reactive to human breast carcinoma and malignant melanoma.
Martin RF; Kisor R; Schroer D; Eichler G; Filaccio ML
Hum Antibodies Hybridomas; 1990; 1(3):154-9. PubMed ID: 2103359
[TBL] [Abstract][Full Text] [Related]
5. Antigen-specific primary immune response of human B-lymphocytes after in vitro immunization with GM3 ganglioside.
Alfonso M; Lanne B; Ifversen P; Vázquez AM; Pérez R; Portoukalian J; Zeuthen J
Hum Antibodies Hybridomas; 1995; 6(3):102-12. PubMed ID: 8597625
[TBL] [Abstract][Full Text] [Related]
6. [Preparation of human monoclonal antibodies reactive with human melanoma and the possibility of clinical application].
Yamaguchi H
Gan To Kagaku Ryoho; 1988 May; 15(5):1677-84. PubMed ID: 2835935
[TBL] [Abstract][Full Text] [Related]
7. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
[TBL] [Abstract][Full Text] [Related]
8. Common human melanoma-associated antigen(s) detected by monoclonal antibodies.
Carrel S; Accolla RS; Carmagnola AL; Mach JP
Cancer Res; 1980 Jul; 40(7):2523-8. PubMed ID: 6155995
[TBL] [Abstract][Full Text] [Related]
9. In vitro growth of B lymphocytes infiltrating human melanoma tissue by transformation with EBV: evidence for secretion of anti-melanoma antibodies by some transformed cells.
Watson DB; Burns GF; Mackay IR
J Immunol; 1983 May; 130(5):2442-7. PubMed ID: 6300247
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of cell-mediated immunity in melanoma patients immunized with murine anti-idiotypic monoclonal antibodies (MELIMMUNE) that mimic the high molecular weight proteoglycan antigen.
Pride MW; Shuey S; Grillo-Lopez A; Braslawsky G; Ross M; Legha SS; Eton O; Buzaid A; Ioannides C; Murray JL
Clin Cancer Res; 1998 Oct; 4(10):2363-70. PubMed ID: 9796966
[TBL] [Abstract][Full Text] [Related]
11. Human monoclonal antibodies against a recombinant HIV envelope antigen produced by primary in vitro immunization. Characterization and epitope mapping.
Ohlin M; Broliden PA; Danielsson L; Wahren B; Rosen J; Jondal M; Borrebaeck CA
Immunology; 1989 Nov; 68(3):325-31. PubMed ID: 2480328
[TBL] [Abstract][Full Text] [Related]
12. Fluctuations in the expression of a glycolipid antigen associated with differentiation of melanoma cells monitored by a monoclonal antibody, Leo Mel 3.
Werkmeister JA; Triglia T; Mackay IR; Dowling JP; Varigos GA; Morstyn G; Burns GF
Cancer Res; 1987 Jan; 47(1):225-30. PubMed ID: 3791209
[TBL] [Abstract][Full Text] [Related]
13. Compartmental distribution of tumor-specific monoclonal antibodies in human melanoma xenografts.
Lin K; Nagy JA; Xu H; Shockley TR; Yarmush ML; Dvorak HF
Cancer Res; 1994 Apr; 54(8):2269-77. PubMed ID: 8174137
[TBL] [Abstract][Full Text] [Related]
14. Tumor-specific T-cell clones recognize different protein determinants of autologous human malignant melanoma cells.
Notter M; Schirrmacher V
Int J Cancer; 1990 May; 45(5):834-41. PubMed ID: 2159436
[TBL] [Abstract][Full Text] [Related]
15. Fine specificity of high molecular weight-melanoma-associated antigen-specific cytotoxic T lymphocytes elicited by anti-idiotypic monoclonal antibodies in patients with melanoma.
Murray JL; Gillogly M; Kawano K; Efferson CL; Lee JE; Ross M; Wang X; Ferrone S; Ioannides CG
Cancer Res; 2004 Aug; 64(15):5481-8. PubMed ID: 15289358
[TBL] [Abstract][Full Text] [Related]
16. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
17. Oncofetal antigen: a tumor-associated fetal antigen immunogenic in man.
Irie RF; Giuliano AE; Morton DL
J Natl Cancer Inst; 1979 Aug; 63(2):367-73. PubMed ID: 88539
[TBL] [Abstract][Full Text] [Related]
18. Identification of subdominant CTL epitopes of the GP100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells.
Tsai V; Southwood S; Sidney J; Sakaguchi K; Kawakami Y; Appella E; Sette A; Celis E
J Immunol; 1997 Feb; 158(4):1796-802. PubMed ID: 9029118
[TBL] [Abstract][Full Text] [Related]
19. Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity.
Clay TM; Custer MC; Sachs J; Hwu P; Rosenberg SA; Nishimura MI
J Immunol; 1999 Jul; 163(1):507-13. PubMed ID: 10384155
[TBL] [Abstract][Full Text] [Related]
20. Tumor-reactive human immunoglobulin G monoclonal antibody from a melanoma patient.
Kan-Mitchell J; White WL; Mitchell MS
Cancer Res; 1989 Aug; 49(16):4536-41. PubMed ID: 2472881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
